Mobile health navigation to improve breast cancer screening in Kenyan women

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study develops and tests a multi-component m-Health package designed to promote uptake of breast cancer screening and early detection in primary care clinics in Kenya. Participants are first engaged to select evidence-based interventions, then assigned to groups and randomized into eight arms to compare different strategies. The aim is to determine feasibility, recruitment, retention, and the most cost-effective approach for improving access to screening services such as mammography and clinical breast exams. The project involves collaboration between Emory University, the National Cancer Institute, and local Kenyan clinics. Outcomes will inform scalable approaches to increase early detection of breast cancer in similar settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* AIM 1: All members of BREAKTHROUGH's Stakeholder Advisory Board (SAB) breast cancer working group
* AIM 1: Participants (patients and health providers) from primary health care clinics in Nairobi County
* AIM 1: Will include women (patients) aged over 35 years and speak either Kiswahili or English
* AIM 1: Include women who:

  * Have never undergone MMG screening
  * Previously undergone MMG screening
  * Experienced breast abnormalities and have been referred for or undergone diagnostic investigations
  * Are currently undergoing or have received breast cancer treatment
* AIM 1: Health care providers and breast screening facility staff (i.e. primary care clinic nurses, MMG clinic staff and technicians) will also be recruited
* AIM 2: Will engage with a diverse group of local and national interagency stakeholders, Nairobi County health leadership, and health providers across different levels of the health system
* AIM 3: Women aged 35 years and older who are able to provide informed consent who are attending the outpatient clinics for primary health care
* AIM 4: Members of SAB breast cancer group, health facilities leadership (all health facility levels)

Exclusion Criteria:

* AIM 1: Those who will be unwilling to consent and those who are unable to consent will be excluded from the study
* AIM 2: Those who will be unwilling to consent and those who are unable to consent will be excluded from the study
* AIM 3: Women undergoing breast cancer treatment and women aged 70 years and above will be excluded
* AIM 4: Members of SAB breast cancer group, and health facilities leadership who will be unwilling and unable to consent will be excluded

Where it's running

• Emory University Hospital/Winship Cancer Institute
  Atlanta, Georgia, United States Recruiting

Study contacts

• Principal investigator: Michael Chung — Emory University Hospital/Winship Cancer Institute

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression

  This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.

  Recruiting at 11 sites City of Hope Medical Center · Arcadia, California and 10 other locations · NCT07741968

• Environmental exposure checks in high-risk and early-onset breast cancer care

  This study tests how patients and providers feel about using environmental exposure risk data in breast cancer care for women at average/high risk or with early-onset breast cancer.

  Recruiting City of Hope Medical Center · Duarte, California · NCT07690852

• CSF sample collection from people with metastatic breast cancer to see brain metastasis risk

  This study tests whether spinal fluid and other samples can help predict brain metastases in adults with metastatic HER2-positive or triple-negative breast cancer who have not yet shown brain involvement.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07619534

• Body composition and outcomes after breast reconstruction

  This study will see if detailed body composition measurements can help predict complications after mastectomy with immediate breast reconstruction in adult women.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07546331

• Support tool for women with HR+ breast cancer on long-term endocrine therapy

  This study tests a SHIELD web- and app-based portal to help women with hormone receptor–positive breast cancer manage symptoms while on long-term endocrine treatment.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07482384

• Personalized Exercise Plan for Breast Cancer Survivors on Chemotherapy

  This trial tests whether adding a guided exercise program to a healthy-lifestyle education plan helps breast cancer patients undergoing chemotherapy maintain fitness, heart health, and quality of life.

  Recruiting at 3 sites Wake Forest University Health Sciences · Winston-Salem, North Carolina and 3 other locations · NCT07474090

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.